Provacan teams with Kanabo to develop 2 all-new, high-strength, 72% CBD formulas to the UK

London - 03-02-2021 (PR Distribution™) -

Provacan, the science-led CBD brand from leading cannabis research company CiiTECH, brings yet again the latest cannabis technology to UK customers with two high potency 72% CBD formulas as part of its popular VapePod range developed in partnership with Kanabo.  

The Provacan range of VapePod® compatible pre-filled pods have grown to become one of the company’s most popular vape products. The VapePod device was developed by Kanabo Group Plc (KNB.L) and provides users with a certified, safe and effective vaporisation system with innovative metered dosing with high bioavailability. Vaporisation of CBD improves the rate of absorption when compared to other means such as ingestion. The device optimises efficiency while delivering CBD formulas more safely and simply than ever before. It can only be used with compatible pre-filled cartridges like Provacan’s Day and Night pre-filled pods.

Kanabo Group Plc recently listed on the London stock exchange. This is a revolutionary step for the VapePod entering the medical cannabis scene in the UK. It is especially vital for medical cannabis patients for whom this delivery method will replace the smoking of cannabis flowers.

Avihu Tamir, CEO at Kanabo Group Plc. said, “We are pleased to have CiiTECH as a partner in the UK for developing pure innovative hemp formulas. The unique formulas are coupled with the VapePod platform which give consumers great satisfaction in knowing that they’re getting the most out of their CBD.”

Building on the popularity of the 55% CBD VapePod­­ range, Provacan has worked with Kanabo Research to launch two new higher strength vape formulas for its customers. The all-new Night Terpene and Day Terpene CBD VapePod formulations contain 72% CBD together with other minor cannabinoids and a potent mix of terpenes.

This blend of terpenes is a proprietary formulation that combines the power of cannabinoids together with terpenes. Terpenes are widely used and can be found in essential oils and aromatherapy. Additionally, the quality of the all natural pods is further enhanced by being  free from traces of pesticides, heavy metals and solvents and not containing PG, VC, MCT, Nicotine nor Vitamin E. 

Provacan is a consumer dedicated, science-led CBD brand that is part of the growing portfolio of brands by leading British cannabis company CiiTECH Ltd, with R&D management based in Israel. Founded by Clifton Flack in 2017, Provacan is the flagship brand within the portfolio and focuses on bringing the latest cannabis technology to its loyal consumers in the UK and across the world. Partnerships with International medical cannabis research companies fuel CiiTECH’s product development and provide brands like Provacan with forward thinking industry knowledge and the ability to create highly respected science-backed CBD products for sale in the UK today.

Eli Whiteman, CiiTECH's VP Business Development says “Our partnership with Kanabo goes back a long way and beyond technological innovation. Our main priority is to strive to ensure our customers have access to a superior combination of bioavailability, unique delivery systems and consistent CBD products that they can rely on. We achieve this by channelling consumer demands into product development and by partnering with like minded medical cannabis companies that do the same”.

The new Night Terpene CBD and Day Terpene CBD VapePods are available from Provacan now, retailing at £49.99 each. To find out more information about the products, visit https://provacan.co.uk/vapes/.

 

For all press enquiries and collaborative media proposals please contact CiiTECH directly.

www.ciitech.co.il | https://provacan.co.uk/

Media Contacts:

Company Name: Provacan
Full Name: Monica Lewin
Phone: +44 8445674343
Email Address: Send Email
Website: http://www.provacan.co.uk

For the original news story, please visit https://www.prdistribution.com/news/provacan-teams-with-kanabo-to-develop-2-all-new-high-strength-72-cbd-formulas-to-the-uk.html.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.